Exploring heterogeneity in mild cognitive impairment

Zachary T Goodman1,2, Maria M Llabre2, Sonya Kaur1

  • 1Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.

PubMed
Abstract

Insights

Mild cognitive impairment (MCI) is highly varied. This study identified six distinct profiles, including those with psychiatric symptoms and frailty, improving diagnostic accuracy for cognitive decline.

Area of Science:

  • Neurology
  • Gerontology
  • Psychiatry

Background:

  • Mild cognitive impairment (MCI) is a complex diagnostic category with an unclear prognosis.
  • MCI is frequently associated with psychiatric symptoms and physical frailty.

Purpose of the Study:

  • To understand the heterogeneity within MCI to improve early detection of cognitive decline.
  • To develop more effective interventions for cognitive impairment.

Main Methods:

  • Cross-sectional multivariate latent mixture analyses of data from 538 older adults.
  • Participants underwent comprehensive neuropsychological, psychiatric, and frailty evaluations.
  • Data were collected between 2015 and 2019 from patients referred to a neurology department.

Main Results:

  • Latent profile analyses identified five cognitive impairment profiles: At-Risk, Pre-MCI, Amnestic MCI, Multiple Domain MCI, and Major Cognitive Impairment.
  • Two additional profiles were identified when including psychiatric symptoms and frailty: Psychiatric/Frail and Multiple Cognitive Domains/Psychiatric/Frail.
  • 55% of individuals classified as healthy based on cognitive data alone were reclassified into different profiles.

Conclusions:

  • Neurologic patients referred for evaluation exhibit significant heterogeneity, including physical and emotional symptoms that increase cognitive decline risk.
  • Findings suggest expanding the traditional paradigm of cognitive impairment for improved diagnostic accuracy.
  • Tailored, precision-driven interventions are needed for better patient outcomes.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
97
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
58